PHASTAR

PHASTAR

Clinical trial data management and statistics

Overview

Phastar is a global data-focused partner that provides statistical consulting, clinical trial reporting, and data management services to pharmaceutical, biotech, and academic clients. Its offerings include bespoke data solutions tailored to each project, delivered by a network of statisticians, programmers, and data scientists across 15 countries. The company works through project-based contracts and consulting fees, using a team-driven approach to ensure accuracy, efficiency, and timely delivery in clinical research. Phastar differentiates itself with its large, internationally distributed biometrics talent and a purpose-driven culture that focuses on matching client needs with customized strategies. Its goal is to accelerate clinical trial programs by delivering high-quality, data-centric solutions that advance research and development in healthcare.

About PHASTAR

Simplify's Rating
Why PHASTAR is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Consulting

Biotechnology

Healthcare

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

London, United Kingdom

Founded

2003

Get referred to PHASTAR

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Graham Clark said January 2026 sponsors want specialist CROs delivering speed and quality.
  • Phastar’s 2026 Boston, Barcelona, Shanghai, and Bournemouth events widen pipeline visibility.
  • Real-time analytics and RBQM content in July 2026 supports higher-value consulting upsells.

What critics are saying

  • Charterhouse-backed specialization faces pressure from bigger CROs like IQVIA and ICON on enterprise deals.
  • Phastar’s 2026 AI messaging commoditizes services if sponsors shift work to automated platforms.
  • Dependence on clinical-trial outsourcing makes a 2027 downturn in biotech funding immediately painful.

What makes PHASTAR unique

  • Phastar’s proprietary framework packages biostatistics, programming, data management, and visualization for submission-ready outputs.
  • Billy Amzal joined June 24, 2025, adding regulatory-grade Bayesian and adaptive-design expertise.
  • B Corp certification and 2025 awards signal a talent-friendly, values-driven CRO brand.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Rutherford Cross
Apr 20th, 2026
Rutherford Cross retained by Phastar to recruit FP&A Business Partner.

Rutherford Cross retained by Phastar to recruit FP&A Business Partner. * April 20, 2026 Rutherford Cross is delighted to be retained by Phastar to appoint its FP&A Business Partner. This role can be fully remote or hybrid depending on location (office space available in Glasgow, Macclesfield and London). Phastar is a multiple award-winning global biometric Contract Research Organisation (CRO) and is accredited by Best Companies as an outstanding organisation to work for. It partners with pharmaceutical, biotechnology, and medical device organisations, providing the expertise and robust processes required to deliver high-quality biostatistics, programming, data management, and data science services on time. With offices across the UK, US, Germany, Denmark, Kenya, Australia, India, China, and Japan, Phastar is the second-largest specialised biometrics provider globally and the largest in the UK. Phastar has an exciting opportunity for an FP&A Business Partner to join the business, reporting to the Head of FP&A. This role is responsible for overseeing and collaborating with the Operational Team, as well as other key senior stakeholders, with the objective of achieving profitable and satisfied clients while meeting favourable KPI targets. The role fully embodies Phastar's company values of Excellence, Collaboration, Innovation, Integrity, and Passion. For full details please view the position profile, and if interested to discuss further, please contact Hazel Wynn, [email protected] Can we help? If you are looking for finance recruitment support, please get in touch with our team of experts.

Clinical Research News
Jun 25th, 2025
Phastar appoints Industry Veteran Billy Amzal as Head of Strategic Consulting

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), today announced the appointment of Billy Amzal as Head of Strategic Consulting.

Clinical Research News
Apr 11th, 2025
Phastar Secures Finalist Spot at 2025 Citeline Awards

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been shortlisted in the 'CRO Partnership of the Year' category at the 2025 Citeline Awards for its collaboration with Medicines Development for Global Health (MDGH), a not for profit pharmaceutical company dedicated to the development of affordable medicines for the people who need them most.

Diagnostics World News
Apr 11th, 2025
Phastar Secures Finalist Spot at 2025 Citeline Awards

London, UK, and Durham (NC), US - April 10th, 2025: Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been shortlisted in the 'CRO Partnership of the Year' category at the 2025 Citeline Awards for its collaboration with Medicines Development for Global Health (MDGH), a not for profit pharmaceutical company dedicated to the development of affordable medicines for the people who need them most.

Clinical Research News
Feb 14th, 2025
Phastar Secures SCOPE US 'Best in Show' Accolade for Clinical Intelligence Platform

Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for PHASTAR right now.

Find jobs on Simplify and start your career today

We update PHASTAR's jobs every few hours, so check again soon! Browse all jobs →